UPC_CFI_504/2023

Intravenous infusion system with dosing device

InfringementMain Infringement ActionDusseldorf LDInfringementCase ClosedSettled at: Pre-merits

Overview Decisions Reasoning Citations Documents Timeline

Coverage: Thin.Reasoning extracted with limited coverage — see decisions tab for full text.

Plain-English summary

Roche and Roche Diabetes Care sued Tandem Diabetes Care and other defendants at the Düsseldorf Local Division for infringement of EP 1 970 677 B1 (intravenous infusion system with dosing device). The action against Tandem Diabetes Care Inc. and Tandem Diabetes Care Europe B.V. settled on confidential terms in June 2025, while proceedings against the remaining defendants (VitalAire, Dinno Santé, Air Liquide Healthcare Nederland) continue.

Accepted arguments

What the court agreed with — by party.

No accepted arguments captured.

Rejected arguments

What the court did not agree with — and why.

No rejected arguments captured.

Key legal principles

Doctrines and rules cited in the reasoning.

partial settlement between claimant and some defendants confirmed under R. 365.1 RoP while proceedings against remaining defendants continue settlement terms remain confidential under R. 365.2 RoP on parties' request settling parties bear their own costs under R. 365.4 RoP

Browse other cases on this principle.